Dupilumab for a 5-year-old child with prurigo nodularis
J Dtsch Dermatol Ges
.
2023 Dec;21(12):1563-1565.
doi: 10.1111/ddg.15243.
Epub 2023 Oct 24.
Authors
Lin Chia-Jen
1
2
,
Li Yun-Chang
3
4
,
Chang Hui-Chin
1
5
6
,
Hsiao Yu-Ping
3
4
Affiliations
1
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2
Department of Medical Education, Chung Shan Medical University Hospital, Taichung, Taiwan.
3
Department of Dermatology, Chung Shan Medical University, Taichung, Taiwan.
4
Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
5
Library, Chung Shan Medical University Hospital, Taichung, Taiwan.
6
Evidence-based Medicine Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
PMID:
37875782
DOI:
10.1111/ddg.15243
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Child, Preschool
Humans
Prurigo* / drug therapy
Substances
dupilumab
Antibodies, Monoclonal, Humanized